Cardiorespiratory and renal responses to arterial chemoreceptor stimulation by hypoxia or almitrine in men.
1. The cardiorespiratory and renal responses to 3 h of normobaric whole-body hypoxic hypoxia (FiO2 = 0.12) as well as to arterial chemoreceptor stimulation by the oral administration of 100 mg almitrine bismesylate during normoxia were measured in 12 normotensive young men undergoing water diuresis. A third series of responses obtained under comparable conditions in the same subjects served as time controls. 2. No significant changes could be detected over time in the parameters measured in control experiments. The subjects reacted to both whole-body hypoxic hypoxia and to pharmacological chemoreceptor stimulation with significant increases in heart rate, tidal volume, minute ventilation and filtration-fraction. Overall renal vascular resistance rose significantly in hypoxia; increases in renal vascular resistance in almitrine experiments were not significant. 3. Renal fractional lithium excretion decreased significantly in response to whole-body hypoxic hypoxia and increased slightly in response to almitrine. Fractional urine and sodium excretion showed negligible changes. 4. The data indicate that, in humans, both almitrine and whole-body hypoxic hypoxia affect not only alveolar ventilation but also renal haemodynamics. 5. The renal electrolyte excretion pattern suggests that under certain circumstances (e.g. dilated renal vascular bed) acute, but well-tolerated, whole-body hypoxic hypoxia can simultaneously stimulate renal proximal tubular sodium reabsorption and inhibit distal tubular sodium reabsorption. The renal tubular responses also indicate that almitrine may influence renal tubular lithium reabsorption by, thus far, unknown mechanisms.
Brauer
H
H
Institute of Physiology, Ernst-Moritz-Arndt-University of Greifswald, Germany.
Gens
A
A
Ledderhos
C
C
Sanchez
R
R
Schuster
R
R
Quies
W
W
Honig
A
A
D000328:Adult; D015765:Almitrine / Q000494:pharmacology*; D001158:Arteries / Q000187:drug effects* / Q000473:pathology; D002319:Cardiovascular System / Q000187:drug effects* / Q000473:pathology; D002628:Chemoreceptor Cells / Q000187:drug effects* / Q000473:pathology*; D006801:Humans; D000860:Hypoxia / Q000473:pathology*; D007668:Kidney / Q000187:drug effects* / Q000473:pathology; D008297:Male; D012137:Respiratory System / Q000187:drug effects* / Q000473:pathology
D015765:Almitrine